First Isolation of Vancomycin-Resistant Enterococcus faecium Carrying Plasmid-Borne

Humans Vancomycin / pharmacology Enterococcus faecium Vancomycin Resistance / genetics Anti-Bacterial Agents / pharmacology Plasmids / genetics Vancomycin-Resistant Enterococci / genetics Gram-Positive Bacterial Infections / drug therapy Microbial Sensitivity Tests
VRE

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
15 11 2022
Historique:
pubmed: 13 10 2022
medline: 18 11 2022
entrez: 12 10 2022
Statut: ppublish

Résumé

Vancomycin-resistant Enterococcus faecium carrying the

Identifiants

DOI: 10.1128/aac.01029-22 PMID: 36222537 PMC: PMC9664843
pubmed: 36222537
doi: 10.1128/aac.01029-22
pmc: PMC9664843
doi:

Substances chimiques

Vancomycin 6Q205EH1VU
Anti-Bacterial Agents 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0102922

Références

Bioinformatics. 2007 Jul 1;23(13):1573-9
pubmed: 17463020
Nucleic Acids Res. 2010 Jan;38(Database issue):D62-8
pubmed: 19906702
Antimicrob Agents Chemother. 2006 Nov;50(11):3966-7
pubmed: 17000737
BMC Bioinformatics. 2008 Sep 16;9:376
pubmed: 18793444
PLoS One. 2021 Jul 23;16(7):e0255187
pubmed: 34297779
J Bacteriol. 1998 Sep;180(18):4886-92
pubmed: 9733692
J Antimicrob Chemother. 2016 Jul;71(7):2052-4
pubmed: 27084917
Bioinformatics. 2018 Mar 15;34(6):1037-1039
pubmed: 29106469
J Bacteriol. 2005 Nov;187(22):7727-37
pubmed: 16267297
Antimicrob Agents Chemother. 2000 May;44(5):1346-8
pubmed: 10770774
Int J Med Microbiol. 2017 Sep;307(6):311-320
pubmed: 28619474
Bioinformatics. 2014 Jul 15;30(14):2068-9
pubmed: 24642063
J Clin Microbiol. 2006 Jul;44(7):2635-7
pubmed: 16825401
J Clin Microbiol. 2002 Sep;40(9):3326-33
pubmed: 12202574
Diagn Microbiol Infect Dis. 2019 Dec;95(4):114883
pubmed: 31495527
J Microbiol Methods. 2018 Feb;145:69-72
pubmed: 29309802
J Clin Microbiol. 2000 Jun;38(6):2392-4
pubmed: 10835012
J Bacteriol. 1999 Jun;181(12):3644-8
pubmed: 10368136
J Bacteriol. 2003 Dec;185(23):7024-8
pubmed: 14617670
Antimicrob Agents Chemother. 2003 Jan;47(1):7-18
pubmed: 12499162
Antimicrob Agents Chemother. 2005 Nov;49(11):4784-6
pubmed: 16251331
Int J Syst Evol Microbiol. 2008 Jun;58(Pt 6):1393-7
pubmed: 18523184
J Hosp Infect. 2016 Apr;92(4):409-10
pubmed: 26876745
J Infect Dis. 1999 Oct;180(4):1177-85
pubmed: 10479146
Clin Microbiol Infect. 2007 Jan;13(1):106-8
pubmed: 17184299
J Antimicrob Chemother. 2004 Sep;54(3):680-3
pubmed: 15308604

Auteurs

Junzo Hisatsune (J)

Antimicrobial Resistance Research Center, National Institute of Infectious Diseasesgrid.410795.e, Higashimurayama, Tokyo, Japan.
Department of Antimicrobial Resistance, Hiroshima University Graduate School of Biomedical & Health Sciences, Hiroshima, Japan.
Hiroshima University Project Research Center for Nosocomial Infectious Diseases, Hiroshima, Japan.

Koichi Tanimoto (K)

Laboratory of Bacterial Drug Resistance, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.

Tadahiro Kohara (T)

Hiroshima University Project Research Center for Nosocomial Infectious Diseases, Hiroshima, Japan.
Department of Oral Surgery, Hiroshima Red Cross and Atomic-bomb Survivors Hospital, Hiroshima, Japan.

Yoshinari Myoken (Y)

Department of Oral Surgery, Hiroshima Red Cross and Atomic-bomb Survivors Hospital, Hiroshima, Japan.

Yoshiharu Tomita (Y)

Laboratory of Bacterial Drug Resistance, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
Department of Bacteriology, Gunma University Graduate School of Medicine, Maebashi, Gunma, Japan.
ORCID: 0000-0001-9969-2235

Motoyuki Sugai (M)

Antimicrobial Resistance Research Center, National Institute of Infectious Diseasesgrid.410795.e, Higashimurayama, Tokyo, Japan.
Department of Antimicrobial Resistance, Hiroshima University Graduate School of Biomedical & Health Sciences, Hiroshima, Japan.
Hiroshima University Project Research Center for Nosocomial Infectious Diseases, Hiroshima, Japan.
ORCID: 0000-0001-9252-7739

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › First Isolation of Vancomycin-Resistant...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Glycopeptides › Vancomycine › First Isolation of Vancomycin-Resistant...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Enterococcaceae › Enterococcus › Enterococcus faecium › First Isolation of Vancomycin-Resistant...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Résistance à la vancomycine › First Isolation of Vancomycin-Resistant...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › First Isolation of Vancomycin-Resistant...
questionsmedicales.fr › Phénomènes génétiques › Structures génétiques › Plasmides › First Isolation of Vancomycin-Resistant...
questionsmedicales.fr › Bactéries › Bactéries à Gram positif › Lactobacillales › Enterococcaceae › Enterococcus › Entérocoques résistants à la vancomycine › First Isolation of Vancomycin-Resistant...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram positif › First Isolation of Vancomycin-Resistant...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › First Isolation of Vancomycin-Resistant...